Burning Rock Biotech Limited (BNR) Misses Q3 EPS by 39c

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q3 EPS of (RMB1.71), RMB0.39 worse than the analyst estimate of (RMB1.32). Revenue for the quarter came in at RMB127.6 million versus the consensus estimate of RMB198 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Sprinklr (CXM) Tops Q2 EPS by 1c, Offers Guidance